期刊文献+

^(99m)Tc-MAG_3-ASON的制备及其在荷乳腺癌裸鼠中的分布 被引量:4

Preparation of ^(99m) Tc-MAG_3-ASON and distribution in breast carcinoma-bearing nude mouse model
下载PDF
导出
摘要 目的:探讨99mTc标记的反义寡核苷酸(ASON)的制备及其在荷乳腺癌裸鼠中的分布。方法:一步法合成巯基乙酰三甘氨酰-N-羟基琥珀酰亚胺酯(NHS-MAG3),并与c-erbB2 mRNA互补的5’末端氨基修饰的15个碱基的ASON偶联;随后进行99mTc的标记,并用Sephadex G25分离纯化99mTc-MAG3-ASON,并评价其稳定性;最后检测其在荷乳腺癌BALB/c裸鼠体内的分布。结果:99mTc-MAG3-ASON平均标记率为70.6%;纯化后,在室温下放置4h,其放化纯度为94.3%;与人血清孵育后,其放化纯度为93.8%;与血浆蛋白结合率为11.8%。乳腺癌组织的摄取率2h达峰值(6.09%ID/g)。结论:以NHS-MAG3为螯合剂制备的99mTc-MAG3-ASON具有良好的稳定性,在乳腺癌部位高浓聚,可望用于肿瘤的显像诊断和治疗。 Objective:To discuss the preparation of ^99mTc labelled antisense oligonucleotide (ASON) and its distribution in breast carcinoma - bearing nude mouse model. Methods : N - hydroxysuccinimide ester of mercaptoacetylglycylglycylglycine ( NHS - MAG3 ) was synthesized by one step. A 15 - mer single - stranded phosphorothioate ASON complementary to c erbB2 oncogene mRNA was coupled with NHS- MAG3 and labelled with ^99mTc subsequently. ^99mTc - MAG3 - ASON was purified on a gel filtration column of Sephadex G25, then its stability was evaluated, and finally the distribution was detected in breast carcinoma bearing nude mice model. Results : The average labeling efficiency of ^99mTc - MAG3 ASON was 70.6 %, and the radiochemical purity was 94.3 % after being labelled at room temperature for 4h. When incubated with fresh human .serum, the radiochmlical purity of 99' c - MAG3 ~ was 93.8 %.The serum protein binding of ^99mTc - MAG3 ASON was 11.8 %. The highest uptake of breast carcinoma was 6.09 % ID/g at 2hs.Conclusion :^99mTc - MAG3-ASON has desirable stability, higher uptake in breast carcinoma and may provide a new sensitive tool for diagnostic imaging and therapy for breast carcinoma in the future.
出处 《重庆医科大学学报》 CAS CSCD 2005年第4期574-577,624,共5页 Journal of Chongqing Medical University
关键词 乳腺癌 反义寡核苷酸(ASON) 巯基乙酰三甘氨酸(MAG3) C-ERBB2 ^99mTc-MAG3-ASON Breast carcinoma Antisense oligonucleotide (ASON) Mercaptoacetylglycylglycylglycine ( MAG3 ) c - erbB2 ^99m Tc -MAG3- ASON
  • 相关文献

参考文献9

  • 1Bonn D. Prospects for antisense therapy are looking brighter [ J ]. Lancet, 1996 ; 347 (9004) : 820.
  • 2Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, et al. Noninvasive imaging of c - myc oncogene messenger RNA with indium - 111 - antisense probes in a mammary tumorbearing mouse model [J ]. J Nucl Med, 1994 ; 35 ( 6 ) : 1054 -1063.
  • 3Fujibayashi Y, Nakagawa K, Waki A, et al. Basic studies on the ^111In labeled antisense oligonucleotide for tumor imaging[J]. Kaku - Igaku, 1996;33(2) : 115 - 122.
  • 4Hnatowich DJ, Winnard PJr, Virzi F, et al. Technetium -99m Labeling of DNA Oligonucleotides[ J ]. J Nucl Med, 1995 ;36(12) :2306 - 2314.
  • 5Winnard P Jr, Chang F, Rusckowski M, et al. Preparation and use of NHS - MAG3 for technetium - 99m labeling of DNA[J]. Nucl Med Biol, 1997;24(5) :425 - 432.
  • 6Blumberg S, Tauber Z. Inhibitron of metalloen-dopeptidases by 2 - mercaptoacetyl - dipeptides [ J ]. Eur J Biochem, 1983 ; 136( 1 ) : 151 - 154.
  • 7杨金巧,王琳,龙启明,胡锐,周蕾蕾,赵俊玲,范伟.^(125)Ⅰ标记抗C-erbB-2单抗对荷人乳腺癌裸鼠的定位诊断及生物学分布[J].中华实验外科杂志,1999,16(3):246-247. 被引量:2
  • 8Maguire H C & Greene M I. The neu (c - erbB2) oncogene[J ]. Semin Oncol. , 1989 ; 16,148 - 155.
  • 9Press M F, Cordon - Cardo C, Slamon D. Expression of the HER - 2/neu proto - oncogene in normal human adult and fetal tissues[J ]. Oncogene, 1990 ; 5,953 - 962.

共引文献1

同被引文献34

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部